Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at Fierce Biotech Webinar on Nov. 28.

Join Dr. Phil Morton, Albumedix' Chief Technology Officer and Dr. Takehiko Kaneko, Head of R&D and Chief Medical Officer of Heartseed, to explore:

  • The journey of Heartseed's investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
  • The value albumin delivers across advanced therapy applications
  • How implementing Recombumin® into a manufacturing process can help improve production and support stability
  • The key benefits of using chemically defined raw materials
  • And more...

For details: